HYBI:NSD-HYBI (USD)

ETF | Others |

Last Closing

USD 48.905

Change

-0.87 (-1.74)%

Market Cap

USD 0.14B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

+1.14 (+2.45%)

USD 50.95B
QQQM Invesco NASDAQ 100 ETF

-11.35 (-6.11%)

USD 39.48B
JEPQ JPMorgan Nasdaq Equity Premium..

-2.75 (-5.57%)

USD 22.06B
ACWI iShares MSCI ACWI ETF

-6.91 (-6.12%)

USD 18.95B
CGABL The Carlyle Group Inc. 4.625% ..

-0.05 (-0.29%)

USD 16.14B
SNDK Sandisk Corp

-8.15 (-21.30%)

USD 5.99B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.02 (+0.03%)

USD 5.17B
NVDL GraniteShares 1.5x Long NVDA D..

-4.79 (-14.76%)

USD 3.76B
TSLL Direxion Shares ETF Trust - Di..

-2.09 (-20.84%)

USD 3.11B
ETHA iShares Ethereum Trust ETF

+0.19 (+1.41%)

USD 2.37B

ETFs Containing HYBI

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.46% 50% F 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.46% 50% F 68% D+
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.14B 69% C- 44% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike